FDA Inspection 1074079 - Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services - December 07, 2018
FDA Inspection 1074079 for Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services on December 07, 2018. Classification: Voluntary Action Indicated (VAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1074079 for Lyophilization Services of New England, Inc. (LSNE) D/B/A PCI Pharma Services on December 07, 2018. Classification: Voluntary Action Indicated (VAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
December 7, 2018
Product Type
Drugs
ID: 7c538adf-a0b1-4e0a-b885-7258322245ed
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox